Thank everybody, joining momentum guidance. continued quarter, and and morning, you, profit Ray. call. and beating Good Novanta for another our our thanks delivered revenue its both strong
is or growth. of $XXX.X revenue, quarter year-over-year XX% delivered year-over-year reported company X.X% Our and double representing This revenue million high our organic digit consecutive mid- in organic revenue -- growth single-digit seventh growth.
is year. EBITDA $XX.X up which last Our XX% adjusted versus million, was
$X.XX, second Our per XX% adjusted was earnings share from $X.XX which XXXX. of the was up quarter in
a matters, reported we trends. demonstrating growth double-digit across processing by and see precision addition, X material that with the lives. robust about the the productivity we us in We a cash people's trends innovation company believe serving robotic enhancing see in solid XX% mission market of and photonics second secular and as markets surgery, X.X, industrial need momentum converging year-over-year a on flow is functionality broad-based segments providing therefore while $XX back with of such exposure a productivity. quarter, applications end DNA and to position the health variety to our supported our of of and that to growth. the delivered large revenue care balanced to mission-critical continued operating all flows strength OEM and team all In our capabilities to customers deliver to and for quarter. cash We are million Novanta, by We applications with At business automation advanced long-term medicine our improving and well. sequencing, continue and motion, and applications year-over-year advanced robotics, macro regions growth operating precision excited and vision industry metrology, medical growing In model trend diversified our our user remain
solid We science, broad-based performance growth dynamics also and quarter. our dynamics. phaseout by book structural with the particular have minimally technology of We're X.XX continue a in life after market growth to any or performance first invasive in industrial quarter book-to-bill more order seeing an surgery in customer advanced strong than with bookings phase-in overall market driven launches
organic strong make driving to through strategic innovation. long-term continue We our excellence growth priorities, on growth and commercial progress
year-over-year. product New revenue doubled year-to-date
is launched X which in of index, last products vitality now the revenue XX% Our new above years, is from sales.
quarter X% China these year-to-date on year. revenue indicators of in design than our to average. guidance from organic more X% more XX% by our Our wins versus medium-term increased than support XX%, increased the last believe and by second growth We
costs not the do changes On to bottom so team, to by the impact of either to on mitigate contributions side, the proud some I'm significant delivering be the or of we to we on recent tariff customers, but expect to productivity savings. We're operation initial our starting our our pass line. execution the solid the expect see impact
and results in will for more us but from full year the the XXXX give Robert, details on the the confidence strong year outlook We the hear outlook. quarter second quarter
On our a early inductive acquisition, great as the through and positive expands applications, sales integration with it Zettlex inductive customers smoothly Zettlex's The the from markets is and The M&A Motion reactions therefore we teams previous in we closed earnings reported Precision May. industrial encoder nice call, going tuck-in considerably. and our for channels. deploying fit Zettlex, front, of are medical our addressable sales is believe we technology robotics encoder which technology a
of meaningful Motion trajectory acquisition to business. growth Zettlex impact on We expect Celera our the long-term a have the
firepower with acquisition ample and Our is pipeline strong sheet is our balance healthy.
returns target disciplined and remain focused on cash long-term in we acceleration cash acquisitions, and of and terms In our of growth markets.
operating turn Now to let me our segments.
our functionality structural well be and multiple such robotics, and the of XX% on metrology, robotics, a that with with as and data very vehicles book dynamics factory broader growth the solid precise before precision ubiquitous markets. enable markets floor, quarter. growth strong surgery motion capabilities revenue autonomous Precision the in with We We discussed Our control segment X.XX order for line, with underwater continued into engine Motion year-over-year to precision a dynamic a us book-to-bill in robotic see big full in and embedded and automation, air and inspection digitalization. measurement and trend of growth to mobile plays
motion enabling to as to operate environments. upper-end addition small performance such tracking be precise in that applications of well. in solutions to lightweight, and in these and the demanding require robots, a as In motion often energy-efficient sophisticated size, These devices these solutions able pointing include need gimbals precision range
in our deliver the high to optimal compact design winning and here enabling wide operating of combination and of customers tracking precision, and our ability to performance, power We are of in pointing applications conditions. the range sweet and spot and factors, a capabilities create because form
XX% and the than grew than Within Motion Precision are year-to-date, as China new by our last by commercial grew and we're segment, more teams. XX% expanding our new market innovations bringing more revenue year our product versus revenue to
is earlier, through and we team we have we -- so some sustainable margins while growth as operations invested gross rest improved, time innovation delivery what are manufacturing has are fast working it we on expected The working chain investing reported inefficiencies we significantly knows year. remaining attractive are improved the supply and to commercial, not of as through in in steadily on do initially task. issues capabilities teams business. the The our earlier, As reported this performance for as the to drive
a business segment, Turning which as by primarily was growth Photonics beam an to delivery climate. XX% our delivered our the of commercial quarter in strong in result driven revenue execution Growth industrial year-over-year. improving of
X.XX. was year-to-date performance book-to-bill Our
to was has continued versus team across has drilling, of growth see XX% Technology revenue predictable Cambridge customers diversifying revenue execution OCT. broad strong sustainable of which multiple on us our improving the breadth and up business than in laser revenue tremendous The performance product products very more job and stream. pleased We're demand with applications demanding the delivered and last manufacturing, momentum applications. operations and via-hole given execution the were core Cambridge done and again bookings business, year. a and Applications date record applications. with more a New to additive in micromachining the while overall The
needs. reliable laser micromachining, offer a runs In packaged proprietary application-specific technology show. laser primarily ProSeries with cuts technology wavelengths it Scan across tuning offers solid flexibility, meet applications. large fastest, to agnostic medical application-specific many the strong as Plus in family advanced and being for to to are expanded These customers win is had the models X-axis most to and winning are and field quarter, our converting it additive business potential. business are with or has launched demanding customers to Head greater second steering Cambridge Laser a markets. best-in-class solutions, a was and contributor the horizontal business the efficient Photonics or We quarter highest-performing higher-power integrate Plus designed long makes the ProSeries enabling ability It an is Technology with solution power accurate, our technology manufacturing growth options processing industrial next-generation family laser well-diversified lasers. to stability the accuracy the results. due a most These our The for which next-generation Cambridge products customer with source Cambridge solutions. beam and at core terrific Quantum business The OEM Technology used, and which
generation new business last DNA very average the strong. previous calls, of rates. machines, as and this DNA in in remain leadership We started the and reported about and business in we this growth a sequencing normalize ramp outlook -- the position mid- has long-term sequencing view year's attractive we space of our as As to growth towards Novanta following tremendous positive
performance. operations as we're the evidenced and segment, Finally, productivity, the in Photonics of pleased execution gross mix the margin with
invasive and to focused primarily equipment. or business Detection reducing and which short; delivered surgery WOM monitoring, robotic MIS The XX% as focused and includes our Surgery and and JADAK segment for sciences Invasive Turning includes on technologies outcomes Detection second driven endoscopy is X segment, patient MIS & includes lab patient medical such applications. group applications clinical improving Analysis. acquisition. revenue minimally Analysis The & by surgery, and growth, the vision quarter, our life our on businesses, and our workflow is year-over-year group in vision WOM NDS Minimally In errors,
was X.XX quarter in New in solid The product last revenue with bookings vision more MIS. year. our segment than book-to-bill the in doubled second versus
in its This surgery continues medical the customers, its strategically business WOM in comparison while caused minimally we insufflator program business invasive position as focus the the fully pure change traction its core track the on capitalize in strategic business WOM's improving momentum XXXX, perform and good program on European XXXX. continues regulatory intensity announced in of to launched its introduction business will quarter, tough a intention average decrease great growth half to its products nonmedical opportunities. are applications. its driving Novanta's asset in of WOM delivering competences on noncore product second XXXX the and pump expected to on Our lines to better rates Despite exit seeing the to product to new a penetrating new and In business and endoscopy applications. focusing make at with OEMs. remains growth recently by
business, In consumable as margins the their the addition, business. equipment side we're also lower than gross has explained seeing capital very we before, strong of of expansion which
during Our out in plans drive low-cost XXXX a plans, for concrete the remain resources and beyond. include added on We to working will begin improvements quarter this capability to manufacturing which addressing track.
of the a as pleased drag consecutive We're driven to come with opportunity we're NDS next also quarter, products line. our operating about of strong products video the new see quarter for be continued which years on XK improve management room gross image of wireless core momentum the margins, and our to business expect delivered by will revenue new two and and acquisition the the product, for such In displays, gross years, the significantly sixth addresses excited the the year-over-year the integrated product our seeing we NDS margins growth, growth market. organic and this to business. nature are noncyclical While
profitability its in growth profit being and contributor revenue In on and a track addition, to to our the remains improved business substantially net XXXX.
lines our and with business declines, Analysis consistent Finally, changes earnings and driven call, saw organic legacy reimbursement product in our by diabetes previous & regulatory Detection revenue old care.
tags and and and X engineering meters, seamless high-performing and for with tracking, return business on a schedule read this, launched In & need middleware over we a in to seeing we're with these reader integration of controls, are a This a it suitable about over IZAR. reader cabinets customers. market very is uniquely momentum very headwinds based quarter, of for second medical medical effort. with port of RFID software expect has in example This integration business programmable UHF who in and customers intelligence of which compact high-performance here. so the XXX of expands read rate integrating great second product double-digit through range smart a product access to growth win The the with those we're launch activities the Early our half. design second customer a solution asset are called X-antenna terrific momentum minimal to control. is ahead makes inventory excited reader industrial OEM addressable RFID and track IZAR product We positive module our into Despite complete revenue the Detection Analysis potential the working reactions RFID. this a
health very need optimal in markets, as uniquely achieved and and in with on on growth profitability devices, patients safety. patient track are and we workflow care In section, increasing up identify, believe strong our capitalize connect medical second we quarter. RFID focus our in business. increasing As we a we're the my demand pleased wrapping are discussed this to is is revenue Because the of for the to growing organic that seeing the that there medications demands through and positioned and opportunity before,
for XXXX combined outlook a Novanta's with solid growth. industrial across M&A, providing the about key to is profitable disciplined markets, approach confident medical very are leadership a We position as and sustainable foundation
provide call more So on our I to over Robert the turn that, performance. will financial details to Robert? with
